| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |